Testing the Combination of Targeted Radiotherapy With Anti-Cancer Drugs, Venetoclax and ASTX-727, to Improve Outcomes for Adults With Newly Diagnosed Acute Myeloid Leukemia
Clinical trial NCT06802523 · SUSPENDED
Trial details
- NCT number
- NCT06802523
- Sponsor
- National Cancer Institute (NCI)
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-21
- Primary completion
- 2028-12-31
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.